Głuszek Stanisław, Kot Marta, Kotucha Bartłomiej, Stępień Renata, Kozieł Dorota
Faculty of Health Sciences, Jan Kochanowski University, Kielce, Poland ; Clinical Ward of General, Oncological, and Endocrine Surgery of the Voivodeship Hospital in Kielce, Poland.
Clinical Ward of General, Oncological, and Endocrine Surgery of the Voivodeship Hospital in Kielce, Poland.
Contemp Oncol (Pozn). 2014;18(5):349-54. doi: 10.5114/wo.2014.43494. Epub 2014 Sep 23.
Cancer located in the oesophagus and gastroesophageal junction is a complex clinical problem and the results of its treatment still remain unsatisfactory. The objective of the study was the clinical analysis of a group of patients with cancer of the oesophagus or gastroesophageal junction, who received combined medical and surgical treatment.
The analysis was performed on a group of 128 patients with the diagnosis of oesophageal cancer or cancer of the gastroesophageal junction. Analysis of medical records and follow-up examinations were used in the research procedure.
From among 128 patients with a diagnosis of oesophageal or gastroesophageal junction cancer, 50 (38.5%) received surgical resections. The surgery most frequently performed (n = 15) was sub-total oesophageal resection according to Akiyama procedure by right-sided thoracotomy (oesophageal anastomosis in the neck). The largest group were patients (n = 26) with stage T3N1M0 of advancement of the disease. In all cases of cancer located in the lower third of the oesophagus, an adenocarcinoma pattern was diagnosed in the histopathological examination, whereas in the case of cancers located in the middle third and upper third of the thoracic oesophagus a carcinoma planoepitheliale pattern was seen. Anastomotic leaks occurred in seven patients (14%). Six patients died during the post-operative period (12%). The mean survival time in the group of analysed patients was two years.
Cancer of the oesophagus or gastroesophageal junction is associated with low resectability, high risk of complications after surgery, and poor oncologic outcome. It is necessary to seek new methods of treatment.
位于食管和胃食管交界处的癌症是一个复杂的临床问题,其治疗结果仍不尽人意。本研究的目的是对一组接受联合药物和手术治疗的食管或胃食管交界癌患者进行临床分析。
对128例诊断为食管癌或胃食管交界癌的患者进行分析。研究过程中采用病历分析和随访检查。
在128例诊断为食管癌或胃食管交界癌的患者中,50例(38.5%)接受了手术切除。最常进行的手术(n = 15)是根据秋山手术通过右侧开胸进行食管次全切除术(颈部食管吻合)。疾病进展为T3N1M0期的患者数量最多(n = 26)。在所有位于食管下三分之一的癌症病例中,组织病理学检查诊断为腺癌模式,而在位于胸段食管中三分之一和上三分之一的癌症病例中,可见扁平上皮癌模式。7例患者(14%)发生吻合口漏。6例患者在术后死亡(12%)。分析患者组的平均生存时间为两年。
食管癌或胃食管交界癌的可切除性低,术后并发症风险高,肿瘤学结局差。有必要寻求新的治疗方法。